<DOC>
	<DOC>NCT00611507</DOC>
	<brief_summary>This phase II trial will evaluate, in first line advanced or metastatic gastric cancer, the efficacy and tolerance of another oxaliplatin, 5FU bolus combination already tested in advanced colorectal cancer</brief_summary>
	<brief_title>A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<criteria>Histologically proven gastric or gastroesophagic junction adenocarcinoma Measurable disease at least in a unidimensional manner. If a unique metastasis constitutes the only disease symptom, histological confirmation will be required Metastatic or locally nonsurgical primary gastric cancer Recurrent gastric cancer after local and/or systemic treatment with a postsurgical period of at least 4 weeks, a postadjuvant chemotherapy period or a neoadjuvant chemoradiotherapy of at least 6 months Serum bilirubin&lt; 2 mg/dl Serum creatinine &lt; or =to 2 times normal superior limit Absolute neutrophil count &gt; or =to 2000/dl Platelet count &gt; or =to 100000/dl Hemoglobin &gt; or =to 10 g/dl AST/ALT &lt; or =to 2.5 times normal superior institutional limit Alkaline phosphatase &lt; or =to 5 times the normal superior institutional limit Age &gt; 18 years Performance Status ECOG 02 Written informed consent signed and dated Symptomatic sensory peripheral neuropathy Uncontrolled concomitant disease.(e.g. severe diabetes mellitus, arterial hypertension) Any other malignancy diagnosed within 5 years previous to the gastric cancer, with the exception of " in situ " cervix carcinoma or nonmelanoma skin cancer Concomitant antitumoral treatment Cerebral metastases Unstable heart disease, even though under treatment Myocardial infarction within the last 6 months Pregnancy or nursing (or women in reproductive life without adequate contraception) Significant neurological or psychiatric disorders</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>